• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Stryker operations fully restored after cyberattack, no material impact expected on 2026 guidance

Stryker operations fully restored after cyberattack, no material impact expected on 2026 guidance

April 10, 2026 By Sean Whooley

This is the logo of Stryker.Stryker (NYSE:SYK) said in an SEC filing that it has fully restored operations across its global systems following a March cyberattack.

On March 11, Stryker disclosed an attack that effectively wiped out data on its Microsoft-based IT system. Handala, an Iran-backed “hacktivist” group, took credit for the cyberattack. The attack forced Stryker to shut down locations around the world and disrupted order processing, manufacturing and shipping.

The attackers claimed on social media platform Telegram that its attack forced the Portage, Michigan–based orthopedic giant to shut down offices in 79 countries. They claimed their effort erased data from more than 200,000 systems, servers and mobile devices. The company launched an investigation and began restoration efforts, bringing its electronic ordering system back and restoring “most” manufacturing as of late March.

In an SEC Form-8K/A filed on April 9, 2026, Stryker said that, as of the date of the filing, it is fully operational across its global manufacturing network. Commercial ordering and distribution systems have also been restored.

Based on the information currently available, Stryker determined that the cyberattack had a material impact on its operations, with resulting impact to its financial results for the first quarter of 2026. However, the company believes the incident has not had, and is not reasonably likely to have, a material impact on its 2026 full-year guidance. For 2026, Stryker anticipates organic net sales growth of 8% to 9.5% and an adjusted EPS between $14.90 and $15.10.

Stryker’s investigation of the incident remains ongoing. It plans to release its first-quarter results on April 30, 2026.

(Learn more about potential ramifications of this attack across medtech from recent MassDevice interviews with cybersecurity experts.)

Filed Under: Business/Financial News, Featured, Health Technology, MassDevice Earnings Roundup, Orthopedic Implants, Orthopedics, Robotic-Assisted, Surgical, Surgical Robotics Tagged With: Cybersecurity, Stryker

More recent news

  • AiM Medical Robotics’ $2M NIH grant and other extra medtech news
  • Intuitive draws on data from 14M cases to back da Vinci systems
  • Ropca wins FDA clearance for ultrasound automation systems
  • Zimmer Biomet lets go of former Nevro CEO amid leadership restructuring
  • Petal Surgical says its first-in-human incisionless surgery is coming soon and offers a first glimpse of its system

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy